is an Aggregator.
DrBioRight is a web platform for natural-language analysis of cancer omics data, backed by a large curated collection of cancer omics datasets. Users search datasets and pose questions in plain language; a large language model-based chatbot turns the questions into analyses, generating and running code and returning visualizations and interpretations. The platform hosts about 508,000 samples across about 4,200 cohorts, spanning RNA expression, protein expression, DNA methylation, DNA mutations, and copy number variation, including molecular, clinical, and functional data from The Cancer Genome Atlas and the Cancer Cell Line Encyclopedia and the RPPA500 functional proteomics compendium of The Cancer Proteome Atlas. DrBioRight is developed by the Han Liang Lab (Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center) and the Jun Li Lab (School of Data and Information Sciences, UNC Chapel Hill), with support from the NIH Informatics Technology for Cancer Research (ITCR) program.
Unknown
No external IDs available
| ID | Name | URL | Category | Format | Description |
|---|---|---|---|---|---|
| drbioright.portal | DrBioRight Platform | drbioright.org | Graphical Interface | http | DrBioRight web platform and LLM-power... |
| drbioright.docs | DrBioRight Documentation | docs | Documentation | http | DrBioRight user documentation describ... |
DrBioRight is a natural-language analytics platform for cancer omics data. Researchers search a curated collection of datasets and ask questions in plain language; an LLM-powered chatbot turns them into analyses, runs the code, and returns figures and interpretations. The platform covers about 508,000 samples in about 4,200 cohorts across RNA expression (170,808 samples / 3,880 cohorts), protein expression (35,982 / 131), DNA methylation (35,106 / 127), DNA mutations (313,698 / 539), and copy number variation (260,122 / 344).
DrBioRight 2.0 added a fine-tuned large language model and the RPPA500 pan-cancer functional proteomics compendium from The Cancer Proteome Atlas (about 7,800 TCGA tumors and 880 CCLE cell lines profiled for 447 protein markers). Molecular, functional, and clinical data come from TCGA (via the GDC) and CCLE (via DepMap); protein markers are linked to MSigDB hallmark gene sets.
The platform is free for academic non-profit institutions; other users need a commercial license (contact support@drbioright.org). The current platform version is 3.2.41 (Platform v3.0 release).
Liu W, Li J, Tang Y, et al. DrBioRight 2.0: an LLM-powered bioinformatics chatbot for large-scale cancer functional proteomics analysis. Nat Commun. 2025;16:2256. doi:10.1038/s41467-025-57430-4
Li J, Chen H, Wang Y, Chen MM, Liang H. Next-Generation Analytics for Omics Data. Cancer Cell. 2021. doi:10.1016/j.ccell.2020.09.002
Created: October 27, 2026 | Last modified: October 27, 2026